Shin-Etsu Chemical’s Silicone Division Is Strengthening Its Initiative to Contribute to Carbon Neutrality
1.7.2021 09:15:00 EEST | Business Wire | Press release
The Silicone Division of Shin-Etsu Chemical Co., Ltd. (Head Office: Tokyo; President, Yasuhiko Saitoh) will implement an investment totaling ¥20 billion to help facilitate its efforts to achieve a reduction in the volume of greenhouse gas emissions.
1. Investment for the reduction in the volume of greenhouse gas emissions in our company’s manufacturing processes.
At the Silicone Division’s main manufacturing plant, the Gunma Complex, we will reduce the greenhouse gas emission volume by 14% compare to that of the present time by further increasing the degree of self-sufficiency in our usage of electric power. The investment amount is for a total of ¥10 billion.
2. Capital investment for the reduction in the volume of greenhouse gas emissions in our customers’ manufacturing processes and the increase of our supply capacity of products used in environmentally friendly products.
We will strengthen our supply capacity of products that contribute to the environment. These include modified silicone fluids, silicone rubber for molding, and heat-dissipation thermal interface silicone materials. The investment amount is for a total of ¥10 billion, and it will be implemented at the Gunma Complex.
Shin-Etsu Chemical is carrying out a Carbon Neutral policy as one of the key issues of management. The Silicone Division has developed and is marketing a millable-type of molding silicone rubber that does not require post-cure in its manufacturing process. By using this product, it became possible to reduce the processing time by about 90%, compared to that needed for the conventional product, and it makes possible energy saving and the improvement of productivity for customers. *
In addition, the applications of the low-density type of silicone rubber that realize lighter-weight rubber molded products are growing in many industrial fields such as automobiles and transportation vehicles like airplanes, as well as in other diverse fields such as wearable devices, and this contributes to energy saving by making them lighter-weight. In addition to these two innovative products we are now marketing, we are developing and supplying many silicone products that contribute to the global environment by such means as helping to achieve reductions in the volume of greenhouse gas emissions.
Towards the realization of Carbon Neutral that Japan as well as other major industrial nations are striving to achieve, Shin-Etsu Chemical will further focus on strengthening our efforts to reduce our company’s greenhouse gas emissions, and at the same time, we will develop, produce and supply products that help facilitate the reduction of emissions, starting with for our customers as well as for society as a whole.
*Comparison data for cases when the 2mm-thickness silicone sheets were produced.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210630006084/en/
Contact information
For inquires about this matter, please contact:
Shin-Etsu Chemical Co., Ltd.
Public Relations Dept.
Tetsuya Koishikawa
Tel: 03-3246-5091, or from outside Japan: 81-3-3246-5091
Fax: 03-3246-5096, or from outside Japan: 81-3-3246-5096
e-mail: sec-pr@shinetsu.jp
www.shinetsu.co.jp/en/
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
4Moving Biotech Announces the Closing of a €12 Million Financing to Advance a First-in-Class DMOAD in Knee Osteoarthritis11.2.2026 13:30:00 EET | Press release
4Moving Biotech (4MB), a clinical-stage biotechnology company and a spin-off of 4P-Pharma, developing a first-in-class disease-modifying osteoarthritis drug (DMOAD) for knee osteoarthritis, today announced the closing of a €12 million financing, completed through a structured and coordinated funding process. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260209500141/en/ Francis Berenbaum (Left) Luc Boblet, Revital Rattenbach, Jérôme Vailland (Right) This financing was secured from a pool of private investors and family offices, who chose to reinforce their commitment by investing directly at the subsidiary level in 4MB. The round includes a combination of equity and loans, reflecting a flexible capital structure aligned with long-term value creation. This closing forms a natural continuum following the €7.6 million France 2030 i-Démo grant announced last year, and the very recent transatlantic extension of the INFLAM-MOTION
Agentic AI Consulting: Sia Accelerates Its Development with More Than 400 Agents on Its Agent Store11.2.2026 13:17:00 EET | Press release
Sia, an international consulting group specializing in strategy, management, and AI, has reached a milestone in its Agentic AI journey. Born in the digital era, the firm now leverages the expertise of more than 3,000 consultants in 19 countries to help organizations scale AI-driven transformation. From GenAI to an Agent Store for All Industries and Functions After unveiling its Generative AI platform to clients in June 2023, the firm announced the launch of its Agent Store in September 2025. Built on a learn-by-design approach, Sia’s Agent Store grew from 50 AI agents to over 400 available for direct consultation, with over a dozen Minimum Viable Products ready for demonstration. Originally introduced as SiaGPT, the platform is now accessible via siagents.ai, reflecting the transition from custom GPTs to fully agentic services. Sia’s AI agents cover a wide range of industries such as Finance, Energy, Public Sector, Healthcare, and Retail and Consumer Goods, and address all corporate fu
BeOne Medicines to Announce Fourth Quarter and Full Year 2025 Financial Results on February 2611.2.2026 13:00:00 EET | Press release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will report its fourth quarter and full year 2025 financial results on Thursday, February 26, 2026 before the financial markets open. Following the release of the financials, the Company will host a live webcast with management at 8:00 a.m. ET. The live webcast of this event can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast. An archived webcast will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics thro
OpenX Strengthens EMEA Leadership with Appointment of Natalie Fisher-Brown11.2.2026 12:05:00 EET | Press release
OpenX Technologies, Inc., one of the world’s leading omnichannel supply-side platforms, today announced the appointment of Natalie Fisher-Brown as Regional Vice President, EMEA Buyer Development. Fisher-Brown will lead, develop, and manage OpenX’s buy-side sales and account management organisations across EMEA, with a focus on strengthening key strategic markets and driving long-term growth for partners. In this new role, Fisher-Brown will oversee the development of senior-level relationships across agencies and brands. She will work closely with well-established and emerging partners to build strategic collaborations that support responsible innovation and sustainable growth. Fisher-Brown’s appointment follows recent hires in France and Germany, reflecting OpenX’s continued investment in market expansion as it evolves the role of the SSP to meet the needs of buyers. Across EMEA, advertisers and agencies are navigating fragmented supply paths, higher expectations around transparency an
TVS Motor Delivers Two iQubes to the Governorate of Vatican City State11.2.2026 11:46:00 EET | Press release
TVS Motor Company, a global leader in two and three-wheeler mobility, and Exelentia are strengthening their commitment to sustainable and responsible mobility by providing the Governorate of Vatican City State with two TVS iQube electric scooters. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260210048491/en/ TVS iQube delivered to Governorate of Vatican State City The official delivery, which took place on February 5th, is part of a consolidated collaboration between the Vatican and Exelentia – which is already active in projects focused on innovation and sustainability. This initiative by Exelentia in a partnership of TVS Motor Italia marks a further concrete step in the ecological transition process already undertaken by the Governorate of Vatican City State. This process aims for zero-emission mobility solutions designed to meet the daily operational needs of a unique context like the Vatican, where efficiency, reliabil
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
